Chromatin-targeting small molecules cause class-specific transcriptional changes in pancreatic endocrine cells
暂无分享,去创建一个
Joshua C. Gilbert | P. Clemons | S. Schreiber | Supriya Gupta | A. Shamji | B. Wagner | Dina Fomina-Yadlin | T. Lewis | S. Kubicek | E. Holson | Bradley Taylor | Yuan Yuan | F. Wagner | T. Luo | Alykhan F. Shamji | Alexander D. Gitlin
[1] Peter A. DiMaggio,et al. A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells. , 2011, Nature chemical biology.
[2] S. Schreiber,et al. Discovery of histone deacetylase 8 selective inhibitors. , 2011, Bioorganic & medicinal chemistry letters.
[3] Jasmine Zain,et al. Romidepsin in the treatment of cutaneous T-cell lymphoma , 2011, Journal of blood medicine.
[4] C. Allis,et al. Covalent histone modifications — miswritten, misinterpreted and mis-erased in human cancers , 2010, Nature Reviews Cancer.
[5] Tomohiro Kono,et al. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells , 2010, Nature.
[6] M. Sodeoka,et al. Total synthesis of (+)-chaetocin and its analogues: their histone methyltransferase G9a inhibitory activity. , 2010, Journal of the American Chemical Society.
[7] James E. Bradner,et al. Chemical Phylogenetics of Histone Deacetylases , 2010, Nature chemical biology.
[8] A. Means,et al. Faculty Opinions recommendation of The ectopic expression of Pax4 in the mouse pancreas converts progenitor cells into alpha and subsequently beta cells. , 2009 .
[9] O. Madsen,et al. The Ectopic Expression of Pax4 in the Mouse Pancreas Converts Progenitor Cells into α and Subsequently β Cells , 2009, Cell.
[10] W-S Xu,et al. Histone deacetylase inhibitors: Potential in cancer therapy , 2009, Journal of cellular biochemistry.
[11] J. Issa,et al. Targeting DNA Methylation , 2009, Clinical Cancer Research.
[12] P. Barter,et al. Cholesterol metabolism and pancreatic β-cell function , 2009, Current opinion in lipidology.
[13] L. Benson,et al. The anticancer agent chaetocin is a competitive substrate and inhibitor of thioredoxin reductase. , 2009, Antioxidants & redox signaling.
[14] J. Snyder,et al. Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294 , 2009, Nature Structural &Molecular Biology.
[15] D. Melton,et al. Extreme makeover: converting one cell into another. , 2008, Cell stem cell.
[16] T. Litman,et al. Molecular Cancer Differential Effects of Class I Isoform Histone Deacetylase Depletion and Enzymatic Inhibition by Belinostat or Valproic Acid in Hela Cells , 2022 .
[17] R. Scharfmann,et al. Histone Deacetylase Inhibitors Modify Pancreatic Cell Fate Determination and Amplify Endocrine Progenitors , 2008, Molecular and Cellular Biology.
[18] P. Atadja,et al. Histone Deacetylase Inhibitor Panobinostat Induces Clinical Responses with Associated Alterations in Gene Expression Profiles in Cutaneous T-Cell Lymphoma , 2008, Clinical Cancer Research.
[19] A. Yoshimura,et al. Antitumor activity of histone deacetylase inhibitors in non-small cell lung cancer cells: development of a molecular predictive model , 2008, Molecular Cancer Therapeutics.
[20] Joshua Close,et al. Exploration of the internal cavity of histone deacetylase (HDAC) with selective HDAC1/HDAC2 inhibitors (SHI-1:2). , 2008, Bioorganic & medicinal chemistry letters.
[21] Alyssa H. Hasty,et al. Direct Effect of Cholesterol on Insulin Secretion , 2007, Diabetes.
[22] P. Marks,et al. Discovery and development of SAHA as an anticancer agent , 2007, Oncogene.
[23] E. Lander,et al. The Mammalian Epigenome , 2007, Cell.
[24] Karl Mechtler,et al. Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase. , 2007, Molecular cell.
[25] Bhaskar Ponugoti,et al. Coordinated Recruitment of Histone Methyltransferase G9a and Other Chromatin-Modifying Enzymes in SHP-Mediated Regulation of Hepatic Bile Acid Metabolism , 2006, Molecular and Cellular Biology.
[26] Michael Rowley,et al. A series of novel, potent, and selective histone deacetylase inhibitors. , 2006, Bioorganic & medicinal chemistry letters.
[27] Paul A Clemons,et al. The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.
[28] J. Mesirov,et al. GenePattern 2.0 , 2006, Nature Genetics.
[29] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[30] Axel Imhof,et al. Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9 , 2005, Nature chemical biology.
[31] Frank Lyko,et al. Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases. , 2005, Cancer research.
[32] Gordon K Smyth,et al. Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[33] P. Jones,et al. Zebularine: a new drug for epigenetic therapy. , 2004, Biochemical Society transactions.
[34] Randall W King,et al. Small Molecule Regulators of Protein Arginine Methyltransferases* , 2004, Journal of Biological Chemistry.
[35] Gordon K Smyth,et al. Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .
[36] M. Daly,et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.
[37] K. Glaser,et al. Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines. , 2003, Molecular cancer therapeutics.
[38] S. Schreiber,et al. Signaling Network Model of Chromatin , 2002, Cell.
[39] C. Allis,et al. Translating the Histone Code , 2001, Science.
[40] S. Schreiber,et al. Genomewide studies of histone deacetylase function in yeast. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[41] K. Panchalingam,et al. Analysis of a Chinese hamster ovary cell mutant with defective mobilization of cholesterol from the plasma membrane to the endoplasmic reticulum. , 1997, Journal of lipid research.
[42] S. Efrat,et al. Regulation of Insulin Secretion from β-Cell Lines Derived from Transgenic Mice Insulinomas Resembles that of Normal β-Cells* , 1990 .
[43] Zachary D. Smith,et al. Unbiased Reconstruction of a Mammalian Transcriptional Network Mediating Pathogen Responses , 2009 .
[44] Gordon K. Smyth,et al. limma: Linear Models for Microarray Data , 2005 .
[45] I. Talianidis,et al. Functional role of G9a-induced histone methylation in small heterodimer partner-mediated transcriptional repression. , 2004, Nucleic acids research.
[46] S. Efrat,et al. Regulation of insulin secretion from beta-cell lines derived from transgenic mice insulinomas resembles that of normal beta-cells. , 1990, Endocrinology.